Cargando…

On the challenges of predicting treatment response in Hodgkin’s Lymphoma using transcriptomic data

BACKGROUND: Despite the advancements in multiagent chemotherapy in the past years, up to 10% of Hodgkin’s Lymphoma (HL) cases are refractory to treatment and, after remission, patients experience an elevated risk of death from all causes. These complications are dependent on the treatment and theref...

Descripción completa

Detalles Bibliográficos
Autores principales: Patrício, André, Costa, Rafael S., Henriques, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10360230/
https://www.ncbi.nlm.nih.gov/pubmed/37474945
http://dx.doi.org/10.1186/s12920-023-01508-9